Trailing-twelve-month (TTM) revenue is $87.53 Million with a year-over-year growth of (10.80%). Revenue represents the total income generated from the company's primary business operations.
Trailing-12-month revenue adds these four fiscal quarters. Amounts are in USD, rounded only to whole currency units.
| Fiscal period | Revenue | Source |
|---|---|---|
| Q3 FY2025Period ended 2025-09-30 | $25,280,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2025-11-04 |
| Q4 FY2025Period ended 2025-12-31 | $15,760,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2026-03-05 |
| Q1 FY2026Period ended 2026-03-31 | $24,454,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2026-05-06 |
| Q2 FY2026Period ended 2026-06-30 | $22,034,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2026-08-06 |
| TTM revenue | $87,528,000 |
Current P/S: $205,515,984 market capitalization ÷ $87,528,000 TTM revenue = 2.35x.
Market capitalization source: FMP quote. Quote observed 2026-10-05T20:00:01.000Z. Latest revenue period ended 2026-06-30.
Current market capitalization comes from the quote provider. EPS weighted-average shares are a separate measure.
These references are supplied through FMP. Full filing context identifiers and dimensional metadata are unavailable in the normalized feed.
Reported quarterly revenue; no daily interpolation. Q2 FY2026 (2026-06-30): $22.03M.
FMP quote market capitalization / revenue from four consecutive issuer fiscal quarters Quote observation: 2026-10-06T12:56:19.548Z. Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation. Historical series through 2026-10-05.
Selected amounts supplied by FMP for each displayed period. Reviewed label references appear where available; other labels are unverified, and items may overlap.
2025-12-31 · USD
Reviewed labels link to their filing; other labels are unverified FMP source labels.
Reviewed presentation labels and parent/child details link to filing evidence; other FMP source labels remain unverified. Mutual exclusivity and reconciliation to a total for the same reporting period and currency have not been verified; percentages and stacked totals are unavailable.
FMP selected disclosures by reporting period. Rows match exact source labels; they may overlap. N/A means no matching disclosure, not zero. Filing links identify reviewed presentation labels for that period.
| FMP source label (unverified unless linked) | FY20242024-12-31 · USD | FY20252025-12-31 · USD |
|---|---|---|
| Reportable Segment | $100M | $99M |
$87.53M
$87.53 Million
(10.80%)
vs. $98.13M a year ago (TTM)
+1.62%
5 Year compound annual growth rate
1 Year
(10.80%)
3 Year
(0.46%)
5 Year
+1.62%
10 Year
+12.31%
15 Year
+6.86%
20 Year
+8.54%
CAGR shows the annualized growth rate over the specified period, smoothing out year-to-year volatility.
| Year | Revenue | YoY Change | % Change |
|---|---|---|---|
| 2025 | $90.07M | ($9.36M) | (9.41%) |
| 2024 | $99.43M | +$4.99M | +5.29% |
| 2023 | $94.44M | +$14.21M | +17.72% |
| 2022 | $80.22M | +$164,000 | +0.20% |
| 2021 | $80.06M | ($2.61M) | (3.16%) |
| 2020 |
TTM Growth
(10.80%)
3-Year CAGR
(0.46%)
5-Year CAGR
+1.62%
Revenue growth vs the same fiscal quarter in the prior fiscal year, last 40 comparable quarters.
| $82.67M |
| +$9.44M |
| +12.90% |
| 2019 | $73.23M | +$70.49M | +2577.44% |
| 2018 | $2.73M | ($29.58M) | (91.54%) |
| 2017 | $32.31M | +$3.31M | +11.43% |
| 2016 | $29.00M | +$2.08M | +7.73% |
